The rhinological side-effects of systemic drugs

Clinical Otolaryngology and Allied Sciences

Volumn 28, Issue 5, 2003, Pages 381-385

  Bateman, Neil D ^a   Woolford, T J ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

Adverse drug reactions; Nasal obstruction; Rhinitis epitaxis

Indexed keywords

ADRENERGIC NEURON BLOCKING AGENT; AGENTS ACTING ON THE EYE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANALGESIC AGENT; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTIVIRUS AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARDIOVASCULAR AGENT; CARVEDILOL; CENTRAL NERVOUS SYSTEM AGENTS; CITALOPRAM; CLOMETHIAZOLE; DERMATOLOGICAL AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXAZOSIN; GASTROINTESTINAL AGENT; GUANETHIDINE; HORMONE DERIVATIVE; HYPNOTIC AGENT; IMMUNOSUPPRESSIVE AGENT; METHYLDOPA; NEUROLEPTIC AGENT; NICOTINIC ACID; ORAL CONTRACEPTIVE AGENT; PHENOTHIAZINE DERIVATIVE; RESERPINE; SILDENAFIL; UNINDEXED DRUG;

DIFFERENTIAL DIAGNOSIS; DRUG EFFECT; DRUG INDUCED DISEASE; DRUG POTENCY; DRUG SAFETY; DRY NOSE; EPISTAXIS; HORMONE SUBSTITUTION; HUMAN; MIGRAINE; NASAL PRURITUS; NOSE CONGESTION; NOSE DISEASE; NOSE OBSTRUCTION; PRIORITY JOURNAL; REVIEW; RHINITIS; RHINORRHEA; SINUSITIS; SMELLING DISORDER; SNEEZING;

ANALGESICS; ANTI-INFECTIVE AGENTS; CARDIOVASCULAR AGENTS; CENTRAL NERVOUS SYSTEM AGENTS; CONTRACEPTIVES, ORAL, HORMONAL; HORMONE REPLACEMENT THERAPY; HUMANS; NASAL MUCOSA; PHARMACEUTICAL PREPARATIONS;

EID: 0141728415     PISSN: 03077772     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2273.2003.00712.x     Document Type: Review

References (33)

1. OGILVIE R.I. & RUEDY J. (1967) Adverse drug reactions during hospitalisation. Can. Med. Assoc J. 97, 1450
2. HURWITZ N. & WADE O.L. (1969) Intensive monitoring of adverse reactions to drugs. BMJ 1, 356
3. RAWLINS M.D. & THOMPSON J.W. (1977) Pathogenesis of adverse drug reactions. In Textbook of Adverse Drug Recations DAVIES, D.M. (ed.), p.10. Oxford University Press, Oxford, UK
4. BRITISH NATIONAL FORMULARY 43 (2002). BMA, London
5. ARONSON J.K. (2001) Side Effects of Drugs Annual 24. Elsevier, Amsterdam
6. DUNCAN C. Monthly Index of Medical Specialities. Haymarket Publishing Services, London
7. STOKSTED P. & THOMSEN K. (1953) Rhinometric measurements for determination of the nasal cycle. Acta Otolaryngologica 109 (Suppl.), 176-181
8. ECCLES R. (1978) The domestic pig as an experimental animal for studies of the nasal cycle. Acta Otolaryngologica 166 (Suppl.), 1-105
9. CLEOPHAS T.J., VAN LIER H.J., FENNIS J.F. et al. (1984) Treatment of Raynaud's syndrome with adrenergic alpha-blockade with or without beta-blockade. Angiology 35, 29-37
10. GONASUN L.M. & LANGRALL H. (1982) Adverse reactions to pindolol administration. Am. Heart J. 104, 482-486
11. TITMARSH S. & MONK J.P. (1987) Terazosin: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in essential hypertension. Drugs 33, 461-477
12. LUTHER R.R., GLASSMAN H.N. ESTEP C.B. et al. (1988) Terazosin, a new selective alpha 1-adrenergic blocking agent. Results of long term treatment in patients with essential hypertension. Am. J. Hypertension 1 (Suppl.), 237S-240S
13. HAIDER Z. & BANO K.A. (1990,) Experience with antihypertensive drug therapy in a hypertension clinic 1972-83 A retrospective analysis. JPMA 40, 91-93
14. FLETCHER A.E. (1991) Adverse effects in the trial of the European Working Party on high blood pressure in the elderly. Am. J. Med. 90 (Suppl.), 42S-44S
15. WEBSTER J. & KOCH H.F. (1996) Aspects of tolerability of centrally acting antihypertensive drugs. J. Cardiovascular Pharmacol. 27 (Suppl. 3), S49-54
16. LEGRAS M.D., SEIFERT B. & CASTRO O. (1990) Neonatal nasal obstruction associated with methyldopa treatment during pregnancy. Am. J. Dis Children 144, 143-144
17. FINNERTY A., LITTLEY M. & REID P. (1986) Enalapril induced nasal blockage. Lancet II, 1395
18. CAPUZZI D.M., GUYTON J.R., MORGAN J.M. et al. (1998) Efficacy and safety of an extended release niacin (Niaspan): a long term study. Am. J. Cardiol. 82, 74U-81U
19. GOLDBERG AM. J. (1998) Cardiol. 82, 35U-38U
20. ELLEGARD E. & KARLSSON G. (1994) Nasal congestion during the menstrual cycle. Clin. Otolaryngol. 19, 400-403
21. BANOVETZ J.D. (1972) Drugs of Choice, MODELL W. (ed.). CV Mosby, St Louis, 645pp
22. ROYAL COLLEGE OF GENERAL PRACTITIONERS (1974) Interim Report on Oral Contraceptives and Health. Royal College of General Practitioners, London
23. ARMENGOT M., BASTERRA J. & MARCO J. (1990) Nasal mucociliary function during the menstrual cycle in healthy women. Revue Laryngologie Otologie Rhinologie 111, 107-109
24. HAEGGSTROM A., OSTBERG B., STJERNA P. et al. (2000) Nasal mucosal swelling and reactivity during a menstrual cycle. Orl. 62, 39-42
25. CARUSO S., GRILLO C., AGNELLO C. et al. (2001) A prospective study evidencing rhinomanometric and olfactometric outcomes in women taking oral contraceptives. Human Reprod. 16, 2288-2294
26. GRILLO G., MANTIA I., TRIOLO C. et al. (2001) Rhinomanometric and olfactometric variations throughout the menstrual cycle. Ann. Otol. Rhinol. Laryngol. 110, 785-789
27. HICKLIN L.A., RYAN C., WONG D.K.K. et al. (2002) Nose-bleeds after sildenafil (Viagra). J. R. Soc. Med. 95, 402-403
28. ORFANOS C.E., KURKA M. & STRUNK V. (1978) Oral treatment of keratosis follicularis with a new aromatic retinoid. Arch. Dermatol. 114, 1211-1214
29. TSAMBAOS D. & ORFANOS C.E. (1983) Antipsoriatic activity of a new synthetic retinoid: the arotinoid RO 13-6298. Arch. Dermatol. 119, 746-751
30. QUIRALTE J., BLANCO C., CASTILLO R. et al. (1996) Intolerance to non-steroidal anti-inflammatory drugs: results of controlled drug challenges in 98 patients. J. Allergy Clin. Immunol. 98, 1225-1234
31. SZCZEKLIK A. & STEVENSON D.D. (1999) Aspirin-induced asthma: advances in pathogenesis and management. J. Allergy Clin. Immunol. 104, 5-13
32. WATSON M.G. & SHENOI P.M. (1990) Drug induced epistaxis. J. R. Soc. Med. 83, 162
33. PRESLEY A.P. (1988) Penicillamine induced rhinitis. BMJ 296, 1332